Therapies for Stroke Prevention in Atrial Fibrillation - CMEZ761

Therapies for Stroke Prevention in Atrial Fibrillation

Update and Review

by Niya Jones, MD, MPH
CMEZ761
(4.6 / 103 ratings )

This course is credentialed for:
Medicine (1.00 Credits)
Physician (1.00 Credits)

ONLINE
Price: $15.00
CE-PRO Price: $7.50

Summary:

Atrial fibrillation affects about 4 million people in the United States. It leads to more than 700,000 hospital admissions each year. Complications related to atrial fibrillation cost the U.S. healthcare system roughly $6 billion annually. Risk factors for atrial fibrillation include age, hypertension, coronary artery disease, diabetes, thyroid disease, and alcohol abuse. Anticoagulation with warfarin, a vitamin K antagonist, has been the mainstay of stroke prevention for patients with atrial fibrillation but presents inherent risks and difficulties. Recently, a number of non-vitamin K antagonist oral anticoagulants, also called novel oral anticoagulants, have been developed for clinical use and are being increasingly used for this purpose.

Objectives:

The goal of this program is to review the use of newer therapies for stroke prevention in atrial fibrillation, including non-vitamin K oral anticoagulants and percutaneous closure of the left atrial appendage. After studying the information presented here, you will be able to:
  • Describe the epidemiology of atrial fibrillation and stroke
  • Discuss the mechanisms of action of non-vitamin K oral anticoagulants
  • Review non-vitamin K oral anticoagulants approved for use in atrial fibrillation
  • Identify common contraindications and adverse effects of non-vitamin K oral anticoagulants
  • Describe the indications for a left atrial appendage closure device
  • Identify areas of practice where various members of the interprofessional team can work together to contribute to the safe and effective use of non-vitamin K oral anticoagulants
 

 
Accreditation Information
 
This course is intended for an interprofessional audience, including physicians, nurses, pharmacists.
 
Physicians: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at ContinuingEducation.com or Nurse.com/CE. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at CEDirect.ContinuingEducation.com and search for this topic title.
 
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
OnCourse Learning is also approved by the Florida Board of Medicine, Florida Board of Osteopathic Medicine, and Florida Physician Assistants (provider # 50-1489).
 
Physician Continuing Education Credit
 
OnCourse Learning designates this enduring activity for a maximum of 1.0 AMA PRA category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
Physician Assistant Continuing Education Credit
 
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hour of Category I credit for completing this program.
 
Disclosures
 
There is no commercial support provided for this online educational activity.

Course Originally Released on: 3/27/2017
Date of Most Recent Review: 3/27/2017
Course Termination/Update Date: 3/27/2020

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

 

For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.

Reports to CE Broker

Sort By
Abigail P - Cutler Bay, FL  ·  Sep 12, 2019
excellent information to incorporate into practice
Was this review helpful?  0
 
Charlene Y - Astoria, NY  ·  Aug 26, 2019
therapies for stroke prevention
Was this review helpful?  0
 
Tara V - Pinehurst, TX  ·  Aug 26, 2019
gggggggggggggggggggggggggggggggggggggggggggggg
Was this review helpful?  0
 
Paulino N - Tampa, FL  ·  Aug 12, 2019
Great review about anticoagulants
Was this review helpful?  0
 
Luisa R - Paterson, NJ  ·  Aug 08, 2019
Questions are appropiate.
Was this review helpful?  0
 
  Page: of 8  
ONLINE
Price: $15.00
CE-PRO Price: $7.50